NCT03833076 is a NA clinical trial of Medical device Procto in Proctological Disorders, sponsored by Nathura S.p.A.

Who is sponsoring NCT03833076?

NCT03833076 is sponsored by Nathura S.p.A.

What drugs are being tested in NCT03833076?

Interventions in NCT03833076: Medical device Procto, Matching placebo.

What condition does NCT03833076 study?

NCT03833076 studies Proctological Disorders.

Is NCT03833076 still recruiting?

NCT03833076 is currently completed. Last updated 23 December 2020.

Last reviewed 2020-12-23 · How we verify

NCT03833076

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A New Class IIb MD in Proctological Disorders

Completed NA Last updated 23 December 2020

What this trial tests

NA trial testing Medical device Procto in Proctological Disorders in 118 participants. Completed in 27 November 2020.

Timeline

22 August 2019

Primary endpoint
27 November 2020

27 November 2020

Quick facts

Lead sponsor	Nathura S.p.A
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	118
Start date	22 August 2019
Primary completion	27 November 2020
Estimated completion	27 November 2020
Sites	1 location across Italy

Drugs / interventions tested

Medical device Procto
Matching placebo — full drug profile →

Conditions studied

Proctological Disorders — all drugs for Proctological Disorders →

Sponsor

Nathura S.p.A

Who can join

Adults 18 to 75, any sex, with Proctological Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is primarily to investigate the performance of a new medical device not yet CE marked in comparison with placebo, in relieving proctological symptomatology in adult patients reporting symptoms of hemorrhoids (grade 1-3), anal fissures and proctitides.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03833076 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nathura S.p.A
Last refreshed: 23 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03833076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing